Vishal Mehta profile page

Vishal founded Ubuntu Research Inc. with a focused mission to bring highly innovative therapies to patients in an expedient, sustainable and contemporaneous manner. With two plus decades of experience in therapeutics development across pharmaceutical, biotechnology and contract research organization (CRO), Vishal has developed deep insights in research and drug development strategies, clinical program execution frameworks and it’s enabling, curated business operations. Vishal is honored to have played a key role in the development of many impactful patient treatments, examples of which include CAR T cellular therapies BREYANZI®, ABECMA®; targeted therapies KISQALI®, AFINITOR®; Immunotherapy YERVOY® as well as biosimilars and multiple life cycle management programs in oncology and other therapeutic areas. Vishal earned his B.S. in Pharmaceutical Sciences from Univ. of Mumbai (India) and MS in Clinical Research & Administration from George Washington University (USA).